NCT02318095 2023-10-26
Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer
Duke University
Phase NA Completed
Duke University
Azienda Ospedaliero-Universitaria di Modena
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
National Cancer Institute (NCI)